GluMind: Multimodal Parallel Attention and Knowledge Retention for Robust Cross-Population Blood Glucose Forecasting
- URL: http://arxiv.org/abs/2509.18457v1
- Date: Mon, 22 Sep 2025 22:27:58 GMT
- Title: GluMind: Multimodal Parallel Attention and Knowledge Retention for Robust Cross-Population Blood Glucose Forecasting
- Authors: Ebrahim Farahmand, Reza Rahimi Azghan, Nooshin Taheri Chatrudi, Velarie Yaa Ansu-Baidoo, Eric Kim, Gautham Krishna Gudur, Mohit Malu, Owen Krueger, Edison Thomaz, Giulia Pedrielli, Pavan Turaga, Hassan Ghasemzadeh,
- Abstract summary: GluMind is a transformer-based multimodal framework for blood glucose forecasting.<n>Cross-attention and multi-scale attention operate in parallel and deliver accurate predictive performance.
- Score: 3.7514590842486295
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: This paper proposes GluMind, a transformer-based multimodal framework designed for continual and long-term blood glucose forecasting. GluMind devises two attention mechanisms, including cross-attention and multi-scale attention, which operate in parallel and deliver accurate predictive performance. Cross-attention effectively integrates blood glucose data with other physiological and behavioral signals such as activity, stress, and heart rate, addressing challenges associated with varying sampling rates and their adverse impacts on robust prediction. Moreover, the multi-scale attention mechanism captures long-range temporal dependencies. To mitigate catastrophic forgetting, GluMind incorporates a knowledge retention technique into the transformer-based forecasting model. The knowledge retention module not only enhances the model's ability to retain prior knowledge but also boosts its overall forecasting performance. We evaluate GluMind on the recently released AIREADI dataset, which contains behavioral and physiological data collected from healthy people, individuals with prediabetes, and those with type 2 diabetes. We examine the performance stability and adaptability of GluMind in learning continuously as new patient cohorts are introduced. Experimental results show that GluMind consistently outperforms other state-of-the-art forecasting models, achieving approximately 15% and 9% improvements in root mean squared error (RMSE) and mean absolute error (MAE), respectively.
Related papers
- Tailoring Adverse Event Prediction in Type 1 Diabetes with Patient-Specific Deep Learning Models [4.201695852847293]
This paper presents a deep learning-based approach for personalized blood glucose prediction.<n>Unlike traditional generalized models, our method accounts for individual variability, enabling more effective subject-specific predictions.<n>Results show that personalized models significantly improve the prediction of adverse events.
arXiv Detail & Related papers (2026-01-21T11:57:51Z) - Beyond Traditional Diagnostics: Transforming Patient-Side Information into Predictive Insights with Knowledge Graphs and Prototypes [55.310195121276074]
We propose a Knowledge graph-enhanced, Prototype-aware, and Interpretable (KPI) framework to predict diseases.<n>It integrates structured and trusted medical knowledge into a unified disease knowledge graph, constructs clinically meaningful disease prototypes, and employs contrastive learning to enhance predictive accuracy.<n>It provides clinically valid explanations that closely align with patient narratives, highlighting its practical value for patient-centered healthcare delivery.
arXiv Detail & Related papers (2025-12-09T05:37:54Z) - AttenGluco: Multimodal Transformer-Based Blood Glucose Forecasting on AI-READI Dataset [8.063401183752347]
Diabetes is a chronic metabolic disorder characterized by persistently high blood glucose levels (BGLs)<n>Recent deep learning models show promise in improving BGL prediction.<n>We propose AttenGluco, a multimodal Transformer-based framework for long-term blood glucose prediction.
arXiv Detail & Related papers (2025-02-14T05:07:38Z) - Hybrid Attention Model Using Feature Decomposition and Knowledge Distillation for Glucose Forecasting [6.466206145151128]
GlucoNet is an AI-powered sensor system for continuously monitoring behavioral and physiological health.<n>We propose a decomposition-based transformer model that incorporates patients' behavioral and physiological data.<n>G GlucoNet achieves a 60% improvement in RMSE and a 21% reduction in the number of parameters, improving RMSE and MAE by 51% and 57%, using data obtained involving 12 participants with T1-Diabetes.
arXiv Detail & Related papers (2024-11-16T05:09:20Z) - FedGlu: A personalized federated learning-based glucose forecasting algorithm for improved performance in glycemic excursion regions [4.073768455373616]
Continuous glucose monitoring (CGM) devices provide real-time glucose monitoring and timely alerts for glycemic excursions.
Rare events like hypoglycemia and hyperglycemia remain challenging due to their infrequency.
We propose a novel Hypo-Hyper (HH) loss function, which significantly improves performance in the glycemic excursion regions.
arXiv Detail & Related papers (2024-08-25T19:51:27Z) - From Glucose Patterns to Health Outcomes: A Generalizable Foundation Model for Continuous Glucose Monitor Data Analysis [47.23780364438969]
We present GluFormer, a generative foundation model for CGM data that learns nuanced glycemic patterns and translates them into predictive representations of metabolic health.<n>GluFormer generalizes to 19 external cohorts spanning different ethnicities and ages, 5 countries, 8 CGM devices, and diverse pathophysiological states.<n>In a longitudinal study of 580 adults with CGM data and 12-year follow-up, GluFormer identifies individuals at elevated risk of developing diabetes more effectively than blood HbA1C%.
arXiv Detail & Related papers (2024-08-20T13:19:06Z) - Deep State-Space Generative Model For Correlated Time-to-Event Predictions [54.3637600983898]
We propose a deep latent state-space generative model to capture the interactions among different types of correlated clinical events.
Our method also uncovers meaningful insights about the latent correlations among mortality and different types of organ failures.
arXiv Detail & Related papers (2024-07-28T02:42:36Z) - Automatic diagnosis of knee osteoarthritis severity using Swin
transformer [55.01037422579516]
Knee osteoarthritis (KOA) is a widespread condition that can cause chronic pain and stiffness in the knee joint.
We propose an automated approach that employs the Swin Transformer to predict the severity of KOA.
arXiv Detail & Related papers (2023-07-10T09:49:30Z) - Machine Learning based prediction of Glucose Levels in Type 1 Diabetes
Patients with the use of Continuous Glucose Monitoring Data [0.0]
Continuous Glucose Monitoring (CGM) devices offer detailed, non-intrusive and real time insights into a patient's blood glucose concentrations.
Leveraging advanced Machine Learning (ML) Models as methods of prediction of future glucose levels, gives rise to substantial quality of life improvements.
arXiv Detail & Related papers (2023-02-24T19:10:40Z) - Predicting Parkinson's Disease with Multimodal Irregularly Collected
Longitudinal Smartphone Data [75.23250968928578]
Parkinsons Disease is a neurological disorder and prevalent in elderly people.
Traditional ways to diagnose the disease rely on in-person subjective clinical evaluations on the quality of a set of activity tests.
We propose a novel time-series based approach to predicting Parkinson's Disease with raw activity test data collected by smartphones in the wild.
arXiv Detail & Related papers (2020-09-25T01:50:15Z) - Short Term Blood Glucose Prediction based on Continuous Glucose
Monitoring Data [53.01543207478818]
This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools.
We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
arXiv Detail & Related papers (2020-02-06T16:39:44Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.